STUDY) Popular semaglutide weight loss drugs may be linked to optic neuropathy causing blindness
By Sharyl Attkisson | July 8, 2024 The following is from MedPage Today. Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective …